Company / Revenue
LENZ Therapeutics, Inc. Revenue History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$19.1M
FY2025
5-year range
$19.1M / $19.1M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#130 of 155
Health Care
What the data says
LENZ Therapeutics, Inc.'s revenue of $19M is lower than 84% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$19M in FY2025.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 155This company $19.1M Sector average $4.5B
▼
-99.6% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.1M | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026